Pathway Health launches workforce development initiative … Florida assisted living provider sued for pregnancy discrimination … Collaborators establish Alzheimer’s disease research center
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Digital ‘communication bridge’ for seniors with aphasia is $13M closer to reality
By
Aaron Dorman
Mar 05, 2024
An upcoming research program will examine the potential for telehealth and wearable sensors to address a specific primary progressive aphasia.
Legislation aims to ensure ‘fair and accurate’ Alzheimer’s treatment coverage decisions
By
Kimberly Bonvissuto
Nov 21, 2023
Federal legislation that would prevent the federal government from imposing wide-reaching coverage restrictions on Alzheimer’s treatments was reintroduced last week, providing “fair and accurate”...
Strategies needed to improve delivery of Alzheimer’s disease-modifying therapies
Jan 30, 2024
Models that enable primary care practitioners to diagnose disease and evaluate patients for treatment eligibility would have biggest effect on wait times, the study found.
Light therapy aids psychobehavioral symptoms with Alzheimer’s disease
Dec 08, 2023
Significant benefits were seen for sleep efficacy, depression and agitation.
Minor neuropsychological deficits indicate risk for progression to Alzheimer’s disease
Oct 13, 2023
For patients with subjective cognitive decline, those with minor neuropsychological deficits have increased cognitive decline and a risk for progression to mild cognitive impairment.
Self-, partner-reported cognitive decline linked to tau
May 30, 2024
Significant associations were seen between self- and study partner-reported Cognitive Function Index and tau driven by elevated Aβ.
Differences ID’d in tau burden in Down syndrome, Alzheimer’s disease
Apr 25, 2024
Differences in spatial distribution, timing and magnitude of tau burden were seen for two genetic forms of Alzheimer’s disease.
Higher education may protect functioning with Alzheimer’s disease
Apr 03, 2024
The findings were seen among African American individuals, with greater protective effect in APOE ɛ4 noncarriers.